We review public and private payer policies, including Medicare Part D and Medicaid rules, and highlight recent policy proposals and industry trends affecting GLP-1 access
The effect varies by medication, dose, and whether the drug is used for diabetes or obesity, but the overall pattern is clear
It helps immune cells communicate and is often spotlighted during cold and flu season because of its role in recovery and repair
A greater reduction in body weight, cholesterol, triglycerides, fasting glucose, insulin, and HOMA-IR was achieved with the higher dose of tirzepatide, demonstrating a clear dose-dependent improvement
[Accessed 9 th September 2025] Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trial